Before the surgery officially began, Scholar Jiang confirmed one last time.
"Wu Ting, have you really thought this through? This is a live surgical broadcast for the patients and their families. There is no room for a single mistake."
Wu Ting confirmed with great confidence, "Scholar Jiang, rest assured, I can do this. And so can the Hybrid Technology."
Wu Ting also had some good news he hadn't yet revealed. With the support of expert professors in the hepatic tumor field from across the country, the clinical trials for the first three stages of a curative therapy for hepatitis B-induced primary liver cancer, which he was leading, were already entering their final phase.
They had already begun compiling and organizing the relevant data. He believed it wouldn't be long before he could take his results and powerfully confront Professor Edwards and the International Liver Cancer Association head-on!
